Both in Pharmaceuticals
Arbutus Biopharma vs Ardelyx
Over the past year ABUS returned −10.0% and ARDX returned −42.4%; their daily moves had a correlation of 0.28.
ABUS −10.0% ARDX −42.4%Growth of $1, one year, split-adjusted
| Metric | ABUS | ARDX |
|---|---|---|
| Price | $4.05 | $3.23 |
| Market cap | $802.3M | $832.7M |
| Today | +4.38% | +6.44% |
| 1 month | −9.6% | −2.6% |
| 6 months | −8.4% | −54.6% |
| Year to date | −15.8% | −44.7% |
| 1 year | −11.6% | −45.5% |
| Revenue growth (YoY) | −90.6% | +15.7% |
| Gross margin | 100.0% | 96.4% |
| Net margin | −512.0% | −0.6% |
| P/E (TTM) | 5.2× | — |
| Price / sales | 4.4× | 1.8× |
| Net cash | $89.5M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 36.7% |
| Short % of float | 15.6% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).